Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Veeva Systems stock currently trades at around 41 times management's adjusted earnings expectation for fiscal 2024. This isn't an outrageous valuation, but it prices in strong earnings growth over ...

Veeva Systems is witnessing a positive estimate revision trend for fiscal 2025. In the past 60 days, the Zacks Consensus Estimate for fiscal 2025 earnings per share (EPS) has moved 22 cents north ...

Overall, Veeva Systems' financials suggest that the company is undervalued when compared to its peers and has strong growth potential, which makes it a compelling investment opportunity for investors.

Brian Stoffel owns shares of Veeva Systems. The Motley Fool owns shares of and recommends Veeva Systems. Try any of our Foolish newsletter services free for 30 days.

Life sciences CRM provider Veeva Systems this afternoon reported fiscal Q4 revenue and profit that topped analysts' expectations, and an outlook that for this quarter's revenue and profit higher ...

Veeva Systems (NYSE: VEEV) and Cerner (NASDAQ: CERN) represent two different ways to invest in the digitization of the healthcare sector.Veeva provides cloud-based customer relationship management ...

Investors this year have bid up shares of Veeva Systems (VEEV), a provider of cloud-based software for the life sciences industry, as the company continues to broaden its product portfolio and ...

Veeva Systems is a cloud software provider with products designed specifically for the life sciences industry. Veeva Systems reported fiscal fourth-quarter earnings on Wednesday, March 1, 2023.

Veeva Systems also added 13 new Vault CRM customers in the fiscal third quarter. In September, VEEV commented on the release of Veeva Site Connect, which is part of the Veeva Clinical Platform.